Perovskite Nanoparticles Toxicity Study on Airway Epithelial Cells

Area of Science:

• Nanomaterial toxicology
• Respiratory cell biology
• Biocompatibility of advanced materials

Background:

• Nanoparticles are increasingly used in consumer products, raising concerns about potential respiratory toxicity.
• Some nanoparticles induce mucus secretion, potentially leading to airway damage.
• Lanthanum strontium manganite (LSM) is vital for solid oxide fuel cells (SOFCs) but its airway cell toxicity is understudied.

Purpose of the Study:

• To investigate the toxicity of Lanthanum Strontium Manganite (LSM) nanoparticles on trachea cells.
• To assess the impact of LSM on cell viability, apoptosis markers, and mucus secretion.
• To evaluate the safety profile of LSM for potential use in applications involving human exposure.

Main Methods:

• Trachea cells were exposed to varying concentrations of LSM nanoparticles (up to 500 μg/ml).
• Cell viability assays were performed.
• Levels of reactive oxygen species (ROS), cytochrome C, and caspase 3 were measured.
• Mucus secretion was quantified to assess LSM's effect.

Main Results:

• LSM nanoparticles exhibited a moderate effect on cell viability, ROS production, cytochrome C, and caspase 3 expression.
• A significant, dose-dependent inhibition of mucus secretion was observed with increasing LSM concentrations.
• LSM did not show significant apoptosis-inducing characteristics in trachea cells.

Conclusions:

• Lanthanum Strontium Manganite (LSM) demonstrates a moderate toxicity profile towards trachea cells.
• LSM significantly reduces mucus secretion, potentially impacting airway clearance mechanisms.
• Further research is needed to fully understand the long-term respiratory implications of LSM exposure.